These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 399655)

  • 1. Experimental animal models of arterial thrombosis and the screening of platelet-inhibiting, anti-thrombotic drugs: a review.
    Philp RB
    Methods Find Exp Clin Pharmacol; 1979 Oct; 1(4):197-224. PubMed ID: 399655
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboregulation by endothelial cells: significance for occlusive vascular diseases.
    Marcus A; Broekman M; Drosopoulos J; Pinsky D; Islam N; Gayle R; Maliszewski C
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):178-82. PubMed ID: 11156849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelets and arterial thrombosis].
    Cazenave JP; Gachet C; Lanza F; Wiesel ML
    Bull Acad Natl Med; 2003; 187(1):35-44; discussion 45-6. PubMed ID: 14556452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet GPIb complex as a target for anti-thrombotic drug development.
    Clemetson KJ; Clemetson JM
    Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
    Breddin K
    Z Gesamte Inn Med; 1984 May; 39(10):234-41. PubMed ID: 6380127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro methods of evaluating antithrombotics and thrombolytics.
    Mousa SA
    Methods Mol Biol; 2010; 663():1-28. PubMed ID: 20617413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents.
    Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new closely related rat models with relevance to arterial thrombosis--efficacies of different antithrombotic drugs.
    Vogel GM; van Amsterdam RG; Zandberg P; van Houwelingen P; Kop WJ; van Mensvoort FW; Meuleman DG
    Thromb Haemost; 1997 Jan; 77(1):183-9. PubMed ID: 9031471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen.
    Nayak MK; Singh SK; Roy A; Prakash V; Kumar A; Dash D
    Thromb Haemost; 2011 Oct; 106(4):624-35. PubMed ID: 21866300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baboon models of acute arterial thrombosis.
    Hanson SR; Harker LA
    Thromb Haemost; 1987 Oct; 58(3):801-5. PubMed ID: 3324380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local lysis therapy in acute arterial thrombosis].
    Roth FJ; Rieser R; Scheffler A
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():427-34. PubMed ID: 1983584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present status of fibrinolytic therapy].
    Koller F
    Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):263-75. PubMed ID: 4771353
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of MGDF on platelet function and thrombosis in animal models.
    Toombs CF
    Stem Cells; 1998; 16 Suppl 2():121-6. PubMed ID: 11012184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs.
    Nichols TC; Bellinger DA; Reddick RL; Read MS; Koch GG; Brinkhous KM; Griggs TR
    Circulation; 1991 Jun; 83(6 Suppl):IV56-64. PubMed ID: 2040072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis.
    Kaiser B; Kirchmaier CM; Breddin HK; Fu K; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 3():35-42. PubMed ID: 10549714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.